Verrica Pharmaceuticals Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2017 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Verrica Pharmaceuticals Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2017 to Q4 2023.
  • Verrica Pharmaceuticals Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $53.7M, a 35.1% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $53.7M +$14M +35.1% Dec 31, 2023 10-K 2024-02-29
Q4 2022 $39.7M +$1.32M +3.43% Dec 31, 2022 10-K 2024-02-29
Q4 2021 $38.4M +$9.55M +33.1% Dec 31, 2021 10-K 2023-03-06
Q4 2020 $28.9M +$13M +82.3% Dec 31, 2020 10-K 2022-03-02
Q4 2019 $15.8M +$8.45M +114% Dec 31, 2019 10-K 2021-03-17
Q4 2018 $7.38M +$5.41M +274% Dec 31, 2018 10-K 2020-03-13
Q4 2017 $1.97M Dec 31, 2017 10-K 2019-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.